Los romances con sistemas de inteligencia artificial son ya una realidad: uno de cada tres hombres jóvenes declara haber tenido una cita con una pareja virtual y cada mes se registran 70 000 búsquedas en internet relacionadas con este tipo de relaciones. Un nuevo estudio ha analizado l …
El alcance de las relaciones románticas con inteligencias artificiales Read More »
Tempus AI’s planned acquisition follows recent interest in blood-based cancer tests across the medtech industry.
Tempus to buy cancer test-maker Personalis for $1.5B Read More »
The insurer, which disclosed the breach in a securities filing late last week, doesn’t yet know how many people may have had their data accessed or what type of data was exposed.
Eli Lilly’s proposed acquisition of AtaiBeckley is “the clearest strategic validation to date” of psychedelics as an emerging pharmaceutical category, according to H.C. Wainwright. The analyst cautioned, however, that the transaction should not be seen as “supporting a uniform re-rating of every psychedelic developer.”
Lilly’s AtaiBeckley buy validates space as Big Pharma takes note of psychedelics Read More »
The supply of the circuit boards needed to fix the devices is significantly constrained, preventing the company from immediately correcting all affected ventilators.
Resmed ventilator safety issue linked to 5 serious injuries Read More »
Having started to publish CRLs without consulting the public, the FDA is under pressure to change course amid concerns it failed to openly and fully evaluate a complex issue.
FDA’s radical transparency policy for rejections runs into legal uncertainty Read More »
The FDA is currently reviewing Vertex Pharmaceuticals’ povetacicept, with a target action date of Nov. 30. If approved, the drug could benefit from campaigns from Novartis and Vera Therapeutics for their recently approved IgAN therapies Fabhalta and Trutakna.
Vertex’s IgA nephropathy drug derisked after Novartis, Vera approvals Read More »
Eighteen companies have gone public this year so far, putting 2026 on pace to record the highest number of IPOs since the pandemic-driven high of 2021.
2026 IPO class blooms again as BlossomHill, Latigo set sights on Nasdaq Read More »
¿Qué ocurre en tu cuerpo cuando sientes una ira incontrolable, un miedo paralizante o una paz profunda? Hoy sabemos perfectamente que el corazón se acelera, las pupilas se dilatan o la respiración se calma gracias al sistema nervioso autónomo. Sin embargo, a princi …
Walter Hess, el Nobel que descubrió cómo las emociones toman el control de tu cuerpo Read More »
Noticias de la actualidad astronómica y astronáutica del 20 de julio de 2026. …
